Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NovoLog approved for use in children

Sep. 16, 2005

Positive opinion issued for Naglazyme for MPS VI in Europe

Sep. 16, 2005

Bexel Pharmaceuticals presents new data on their antidiabetic candidates

Sep. 16, 2005

CTCE-0214 supports stem-cell expansion and engraftment

Sep. 16, 2005

Plant extracts demonstrate antidiabetic activity

Sep. 16, 2005

Pharmacokinetic profile of NBI-12i in rats

Sep. 16, 2005

E1-I.N.T. studied in type 2 diabetes patients

Sep. 15, 2005

Novel glucagon inhibitor shows promise for type 2 diabetes

Sep. 15, 2005

Novel agents imparted for the treatment of obesity and lipoprotein disorders

Sep. 15, 2005

New data on the metabolic effects of SOM-230 in patients with acromegaly

Sep. 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...